Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trialsBernard Asselain|The Lancet Oncology|2017Cited by 1.1k
First-in-human phase I study of the DNA repair inhibitor DT01 in combination with radiotherapy in patients with in transit melanoma.Christophe Le Tourneau, Marie Dutreix, Youlia Kirova et al.|Journal of Clinical Oncology|2015Cited by 1